The Genotype and Phenotype of Lymphangioleiomyomatosis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06405997

Enrollment

100

Registered

2024-05-09

Start date

2024-05-10

Completion date

2027-07-31

Last updated

2024-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sporadic Lymphangioleiomyomatosis, TSC-associated Lymphangioleiomyomatosis

Keywords

Lymphangioleiomyomatosis

Brief summary

This study aims to differentiate between sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex-associated Lymphangioleiomyomatosis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age ≥ 18 y/o * Patient with Chest CT showed cystic lung disease, suspected Lymphangioleiomyomatosis

Exclusion criteria

* age \< 18 y/o

Design outcomes

Primary

Measure	Time frame
The genotype and phenotype of lymphangioleiomyomatosis	one month

Countries

Taiwan

Contacts

Primary ContactYao-Wen Kuo

kyw@ntu.edu.tw0972-651-821

Outcome results